STOCK TITAN

Biofrontera Inc. to Report Second Quarter Financial Results on August 11, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Biofrontera Inc. (Nasdaq:BFRI) will report financial results for the three and six months ended June 30, 2023 before the opening of the U.S. financial markets on Friday, August 11, 2023. The company will hold a conference call to discuss those results, provide a business update, and answer questions.
Positive
  • None.
Negative
  • None.

WOBURN, MA / ACCESSWIRE / August 4, 2023 / Biofrontera Inc. (Nasdaq:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three and six months ended June 30, 2023 before the opening of the U.S. financial markets on Friday, August 11, 2023. The Company will hold a conference call that same day beginning at 8:30 a.m. Eastern time to discuss those results, provide a business update and answer questions.

Conference Call and Webcast Information

Event:Biofrontera Inc. Second Quarter 2023 Financial Results and Business Update Conference Call
Date:Friday, August 11, 2023
Time:8:30 a.m. Eastern time
Conference call:

1-877-877-1275 (U.S.)

1-412-858-5202 (international)

Webcast:Live and 90-day replay webcast are available here and at investors.biofrontera-us.com.

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of products for the treatment of dermatologic conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com and follow Biofrontera on LinkedIn and Twitter.

Contact:

LHA Investor Relations
Tirth T. Patel
212-201-6614
tpatel@lhai.com

# # #

SOURCE: Biofrontera Inc.



View source version on accesswire.com:
https://www.accesswire.com/772232/Biofrontera-Inc-to-Report-Second-Quarter-Financial-Results-on-August-11-2023

FAQ

When will Biofrontera Inc. (Nasdaq:BFRI) report its financial results for the three and six months ended June 30, 2023?

Biofrontera Inc. (Nasdaq:BFRI) will report its financial results on Friday, August 11, 2023 before the opening of the U.S. financial markets.

What time will the conference call regarding the financial results and business update take place?

The conference call will begin at 8:30 a.m. Eastern time on Friday, August 11, 2023.

How can I join the conference call?

You can join the conference call by dialing 1-877-877-1275 (U.S.) or 1-412-858-5202 (international).

Where can I access the webcast of the conference call?

The live and 90-day replay webcast are available at investors.biofrontera-us.com.

Biofrontera Inc.

NASDAQ:BFRI

BFRI Rankings

BFRI Latest News

BFRI Stock Data

7.58M
5.59M
32.06%
20.68%
8.25%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
WOBURN